Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion
about
Targeting hypoxia to overcome radiation resistance in head & neck cancers: real challenge or clinical fairytale?Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients.Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.Biological imaging in clinical oncology: radiation therapy based on functional imaging.Correlation of pretreatment 18F-FDG PET tumor textural features with gene expression in pharyngeal cancer and implications for radiotherapy-based treatment outcomes.Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck.Immunohistochemical studies and fluorodeoxyglucose uptake on positron emission tomography in pharyngeal cancer for predicting radiotherapy-based treatment outcomes.Dramatic response of CTNNB1 and VEGFR-2 mutant temporal bone squamous cell carcinoma to bevacizumab in combination with pemetrexed.Immunohistochemical biomarkers and volumetric parameters for predicting radiotherapy-based outcomes in patients with p16-negative pharyngeal cancer
P2860
Q30388849-4B00164A-926C-4C83-B6D7-F4018ACF08A3Q37024656-209C5BB6-0C96-47B2-ADCE-E06D179AB27DQ38697010-4BA22551-D058-41A5-9BDC-BDDB7A527A7AQ38887987-9DEBEDA2-7AC3-4123-B96E-E034ADA0A210Q39079577-27235F9B-CB99-46C2-9DEC-2565D6509CB1Q39156367-DA5E9235-2CE1-4E02-AF8A-63117BA88888Q39268251-45EB79F8-9850-40F9-8DF8-EAD1EC88E2A7Q41339198-C68BD56E-0665-4248-8F7C-364BA7AD32EDQ42654029-A0595B42-E843-4965-8CF6-CD24198983BC
P2860
Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase 1 trial of bevacizumab w ...... , proliferation, and perfusion
@ast
Phase 1 trial of bevacizumab w ...... , proliferation, and perfusion
@en
type
label
Phase 1 trial of bevacizumab w ...... , proliferation, and perfusion
@ast
Phase 1 trial of bevacizumab w ...... , proliferation, and perfusion
@en
prefLabel
Phase 1 trial of bevacizumab w ...... , proliferation, and perfusion
@ast
Phase 1 trial of bevacizumab w ...... , proliferation, and perfusion
@en
P2093
P2860
P921
P1476
Phase 1 trial of bevacizumab w ...... , proliferation, and perfusion
@en
P2093
Anne M Traynor
David T Yang
Deepak Khuntia
Gregory K Hartig
Lindell R Gentry
Matthew J Nyflot
Paul M Harari
Peggy A Wiederholt
Robert Jeraj
Tien Hoang
P2860
P304
P356
10.1016/J.IJROBP.2014.11.029
P407
P50
P577
2015-02-03T00:00:00Z